Healthcare provider profile · identity verified

Mary S Lee, MD

Internal Medicine · WEST BLOOMFIELD, MI · NPI 1932180817

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	335	93
Levothyroxine Sodium	Levothyroxine Sodium	272	72
Rosuvastatin Calcium	Rosuvastatin Calcium	258	81
Omeprazole	Omeprazole	250	72
Losartan Potassium	Losartan Potassium	228	59
Amlodipine Besylate	Amlodipine Besylate	213	56
Metoprolol Succinate	Metoprolol Succinate	195	57
Methylprednisolone	Methylprednisolone	137	93
Meloxicam	Meloxicam	125	46
Sertraline Hcl	Sertraline Hcl	117	33
Pantoprazole Sodium	Pantoprazole Sodium	111	33
Gabapentin	Gabapentin	106	34
Simvastatin	Simvastatin	103	27
Montelukast Sodium	Montelukast Sodium	101	28
Lisinopril	Lisinopril	99	24
Alprazolam	Alprazolam	94	28
Metformin Hcl	Metformin Hcl	90	25
Prednisone	Prednisone	90	58
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	85	55
Duloxetine Hcl	Duloxetine Hcl	83	22
Mounjaro	Tirzepatide	83	18
Tramadol Hcl	Tramadol Hcl	82	16
Atenolol	Atenolol	75	21
Eliquis	Apixaban	74	20
Zolpidem Tartrate	Zolpidem Tartrate	73	13
Hydrochlorothiazide	Hydrochlorothiazide	71	19
Furosemide	Furosemide	69	24
Jardiance	Empagliflozin	67	16
Doxycycline Hyclate	Doxycycline Hyclate	65	54
Albuterol Sulfate Hfa	Albuterol Sulfate	62	27
Buspirone Hcl	Buspirone Hcl	62	18
Azithromycin	Azithromycin	61	47
Ezetimibe	Ezetimibe	60	21
Potassium Chloride	Potassium Chloride	60	19
Clopidogrel	Clopidogrel Bisulfate	54	11
Cefuroxime	Cefuroxime Axetil	51	34
Famotidine	Famotidine	51	20
Benazepril Hcl	Benazepril Hcl	50	14
Mirtazapine	Mirtazapine	48	21
Carvedilol	Carvedilol	46	13
Methocarbamol	Methocarbamol	45	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	34
Ozempic	Semaglutide	45	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	16
Trazodone Hcl	Trazodone Hcl	44	15
Tamsulosin Hcl	Tamsulosin Hcl	43	11
Citalopram Hbr	Citalopram Hydrobromide	40	13
Azelastine Hcl	Azelastine Hcl	39	21
Meclizine Hcl	Meclizine Hcl	38	20
Spironolactone	Spironolactone	38	11
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	11
Metoprolol Tartrate	Metoprolol Tartrate	36	11
Paxlovid	Nirmatrelvir/Ritonavir	36	36
Escitalopram Oxalate	Escitalopram Oxalate	35	13
Ondansetron Odt	Ondansetron	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	20
Eszopiclone	Eszopiclone	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Hydrocortisone	Hydrocortisone	26	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	11
Clonazepam	Clonazepam	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Lubiprostone	Lubiprostone	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Temazepam	Temazepam	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	20	suppressed
Cephalexin	Cephalexin	20	13
Diazepam	Diazepam	20	13
Levofloxacin	Levofloxacin	20	15
Amoxicillin	Amoxicillin	19	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Estradiol	Estradiol	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Topiramate	Topiramate	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Valsartan	Valsartan	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Amiloride Hcl	Amiloride Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Emgality Pen	Galcanezumab-Gnlm	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Naproxen	Naproxen	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Xanax	Alprazolam	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Diclofenac Potassium	Diclofenac Potassium	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Glipizide	Glipizide	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error